Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 21 |
| Apr 2026 | 0 | 7 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2023 Filed Mar 1, 2023 21:06 UTC |
Schenkein David PDirector
|
SaleCommon stock | 20,000 | $25.37 | $507,400.00 |
DisclosureSEC source: 0001439222-23-000041 · wf-form4_167770476285855.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,879 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $25.11 to $25.74. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:06 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 20,000 | $9.05 | $181,000.00 |
DisclosureSEC source: 0001439222-23-000041 · wf-form4_167770476285855.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 16, 2023 Filed Feb 16, 2023 21:03 UTC |
FOUSE JACQUALYN ADirector
|
Tax withholdingCommon stock | 3,648 | $28.91 | $105,463.68 |
DisclosureSEC source: 0001439222-23-000024 · wf-form4_167658141141317.xml · nonDerivative · entry 2 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,582 Read SEC document |
| February 16, 2023 Filed Feb 16, 2023 21:04 UTC |
Burns James WilliamChief Legal Officer
|
Tax withholdingCommon stock | 609 | $28.91 | $17,606.19 |
DisclosureSEC source: 0001439222-23-000025 · wf-form4_167658143694129.xml · nonDerivative · entry 2 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,538 Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:05 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
SaleCommon stock | 233 | $27.21 | $6,339.93 |
DisclosureSEC source: 0001439222-23-000028 · wf-form4_167701349283143.xml · nonDerivative · entry 1 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,668 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 14, 2023 Filed Feb 14, 2023 21:07 UTC |
Gheuens SarahChief Medical Officer
|
Tax withholdingCommon stock | 758 | $28.44 | $21,557.52 |
DisclosureSEC source: 0001439222-23-000017 · wf-form4_167640880440163.xml · nonDerivative · entry 2 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,009 Read SEC document |
| February 14, 2023 Filed Feb 14, 2023 21:07 UTC |
Burns James WilliamChief Legal Officer
|
Tax withholdingCommon stock | 643 | $28.44 | $18,286.92 |
DisclosureSEC source: 0001439222-23-000018 · wf-form4_167640884813599.xml · nonDerivative · entry 2 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,409 Read SEC document |
| February 14, 2023 Filed Feb 14, 2023 21:06 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
Tax withholdingCommon stock | 273 | $28.44 | $7,764.12 |
DisclosureSEC source: 0001439222-23-000016 · wf-form4_167640875313872.xml · nonDerivative · entry 2 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,172 Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:03 UTC |
FOUSE JACQUALYN ADirector
|
Exercise / conversionRestricted stock units · Derivative | 11,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000024 · wf-form4_167658141141317.xml · derivative · entry 3 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 11,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:03 UTC |
FOUSE JACQUALYN ADirector
|
Exercise / conversionCommon stock | 11,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000024 · wf-form4_167658141141317.xml · nonDerivative · entry 1 FOUSE JACQUALYN A · CIK 0001405288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:04 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
Exercise / conversionRestricted stock units · Derivative | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000026 · wf-form4_167658147701426.xml · derivative · entry 4 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. F3 · derivative.expiration_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:04 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
SaleCommon stock | 504 | $28.59 | $14,409.36 |
DisclosureSEC source: 0001439222-23-000026 · wf-form4_167658147701426.xml · nonDerivative · entry 3 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,901 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:04 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
Tax withholdingCommon stock | 127 | $28.91 | $3,671.57 |
DisclosureSEC source: 0001439222-23-000026 · wf-form4_167658147701426.xml · nonDerivative · entry 2 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,405 Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:04 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
Exercise / conversionCommon stock | 360 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000026 · wf-form4_167658147701426.xml · nonDerivative · entry 1 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:04 UTC |
Burns James WilliamChief Legal Officer
|
Exercise / conversionRestricted stock units · Derivative | 1,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000025 · wf-form4_167658143694129.xml · derivative · entry 3 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 1,738 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 21:04 UTC |
Burns James WilliamChief Legal Officer
|
Exercise / conversionCommon stock | 1,738 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000025 · wf-form4_167658143694129.xml · nonDerivative · entry 1 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:03 UTC |
Schenkein David PDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001439222-23-000020 · wf-form4_167649497047928.xml · derivative · entry 5 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,363 Underlying: Common stock · 20,000 shares Expires 2023-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:03 UTC |
Schenkein David PDirector
|
SaleCommon stock | 20,000 | $28.62 | $572,400.00 |
DisclosureSEC source: 0001439222-23-000020 · wf-form4_167649497047928.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,879 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $28.25 to $28.94. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:03 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 20,000 | $9.05 | $181,000.00 |
DisclosureSEC source: 0001439222-23-000020 · wf-form4_167649497047928.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:07 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionRestricted stock units · Derivative | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000017 · wf-form4_167640880440163.xml · derivative · entry 3 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,162 Underlying: Common stock · 2,162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:07 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionCommon stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000017 · wf-form4_167640880440163.xml · nonDerivative · entry 1 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:07 UTC |
Burns James WilliamChief Legal Officer
|
Exercise / conversionRestricted stock units · Derivative | 1,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000018 · wf-form4_167640884813599.xml · derivative · entry 3 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,833 Underlying: Common stock · 1,834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. F2 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:07 UTC |
Burns James WilliamChief Legal Officer
|
Exercise / conversionCommon stock | 1,834 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000018 · wf-form4_167640884813599.xml · nonDerivative · entry 1 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:06 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
Exercise / conversionRestricted stock units · Derivative | 777 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000016 · wf-form4_167640875313872.xml · derivative · entry 4 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 777 Underlying: Common stock · 777 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. F4 · derivative.expiration_date: The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:06 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
Exercise / conversionCommon stock | 777 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000016 · wf-form4_167640875313872.xml · nonDerivative · entry 1 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 119 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| February 01, 2023 Filed Feb 14, 2023 21:06 UTC |
Washburn Theodore James Jr.Principal Accounting Officer
|
GrantRestricted stock units · Derivative | 6,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000016 · wf-form4_167640875313872.xml · derivative · entry 3 Washburn Theodore James Jr. · CIK 0001874199 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,896 Underlying: Common stock · 6,896 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025. F3 · derivative.expiration_date: The restricted stock units were granted on February 1, 2023. The shares underlying the restricted stock units will vest in full on February 1, 2025. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:04 UTC |
Schenkein David PDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001439222-23-000010 · wf-form4_167528545373635.xml · derivative · entry 6 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,363 Underlying: Common stock · 20,000 shares Expires 2023-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:04 UTC |
Schenkein David PDirector
|
SaleCommon stock | 3,300 | $29.88 | $98,604.00 |
DisclosureSEC source: 0001439222-23-000010 · wf-form4_167528545373635.xml · nonDerivative · entry 3 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,879 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $29.71 to $30.32. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:04 UTC |
Schenkein David PDirector
|
SaleCommon stock | 16,700 | $29.22 | $487,974.00 |
DisclosureSEC source: 0001439222-23-000010 · wf-form4_167528545373635.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,179 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $28.69 to $29.69. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 21:04 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 20,000 | $9.05 | $181,000.00 |
DisclosureSEC source: 0001439222-23-000010 · wf-form4_167528545373635.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:03 UTC |
Schenkein David PDirector
|
Exercise / conversionStock option (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001439222-23-000008 · wf-form4_167416220784481.xml · derivative · entry 6 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,363 Underlying: Common stock · 20,000 shares Expires 2023-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: This option was originally granted on April 30, 2013 for the purchase of 136,363 shares of common stock. The option vests as to 50% of the underlying shares upon the achievement of a performance milestone, and as to the remaining 50% of upon the achievement of a second performance milestone. The Company's board of directors determined that the first performance milestone was achieved on December 3, 2015, resulting in the vesting of this option as to 68,181 shares. On January 26, 2017, the Company's board of directors determined that the second performance milestone was achieved, resulting in the vesting of this option as to the remaining 68,182 shares. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:03 UTC |
Schenkein David PDirector
|
SaleCommon stock | 1,034 | $29.49 | $30,492.66 |
DisclosureSEC source: 0001439222-23-000008 · wf-form4_167416220784481.xml · nonDerivative · entry 3 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,879 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $29.42 to $29.65. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:03 UTC |
Schenkein David PDirector
|
SaleCommon stock | 18,966 | $28.82 | $546,600.12 |
DisclosureSEC source: 0001439222-23-000008 · wf-form4_167416220784481.xml · nonDerivative · entry 2 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,913 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $28.42 to $29.39. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:03 UTC |
Schenkein David PDirector
|
Exercise / conversionCommon stock | 20,000 | $9.05 | $181,000.00 |
DisclosureSEC source: 0001439222-23-000008 · wf-form4_167416220784481.xml · nonDerivative · entry 1 Schenkein David P · CIK 0001578200 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 13, 2023 Filed Jan 18, 2023 21:09 UTC |
Foster-Cheek Kaye IDirector
|
GiftCommon stock | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000006 · wf-form4_167407612959834.xml · nonDerivative · entry 1 Foster-Cheek Kaye I · CIK 0001312622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,549 Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:11 UTC |
Milanova TsvetaChief Commercial Officer
|
GrantRestricted stock units · Derivative | 25,426 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-23-000004 · wf-form4_167295304325378.xml · derivative · entry 2 Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,426 Underlying: Common stock · 25,426 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on January 3, 2023. Beginning on January 3, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. F3 · derivative.expiration_date: The restricted stock units were granted on January 3, 2023. Beginning on January 3, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:11 UTC |
Milanova TsvetaChief Commercial Officer
|
GrantStock option (right to buy) · Derivative | 135,682 | $0.00 Strike: $27.53 | $0.00 |
DisclosureSEC source: 0001439222-23-000004 · wf-form4_167295304325378.xml · derivative · entry 1 Milanova Tsveta · CIK 0001957180 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,682 Underlying: Common stock · 135,682 shares Expires 2033-01-03 F1 · derivative.exercise_date: This option was granted on January 3, 2023. The shares underlying this option vest as to 25% of the underlying shares on January 3, 2024, with the remaining 75% vesting in 36 equal monthly installments thereafter. Read SEC document |
| December 28, 2022 Filed Dec 28, 2022 21:05 UTC |
Gheuens SarahChief Medical Officer
|
Tax withholdingCommon stock | 2,783 | $28.48 | $79,259.84 |
DisclosureSEC source: 0001439222-22-000104 · wf-form4_167226148971361.xml · nonDerivative · entry 2 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,605 Read SEC document |
| December 28, 2022 Filed Dec 28, 2022 21:05 UTC |
Burns James WilliamChief Legal Officer
|
Tax withholdingCommon stock | 2,597 | $28.48 | $73,962.56 |
DisclosureSEC source: 0001439222-22-000105 · wf-form4_167226150591374.xml · nonDerivative · entry 2 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,218 Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:05 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionRestricted stock units · Derivative | 9,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-22-000104 · wf-form4_167226148971361.xml · derivative · entry 3 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 9,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022. F2 · derivative.expiration_date: The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:05 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionCommon stock | 9,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-22-000104 · wf-form4_167226148971361.xml · nonDerivative · entry 1 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:05 UTC |
Burns James WilliamChief Legal Officer
|
Exercise / conversionRestricted stock units · Derivative | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-22-000105 · wf-form4_167226150591374.xml · derivative · entry 3 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 8,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022. F3 · derivative.expiration_date: The restricted stock units were granted on December 23, 2020. The shares underlying the restricted stock units will vest in full on December 23, 2022. Read SEC document |
| December 23, 2022 Filed Dec 28, 2022 21:05 UTC |
Burns James WilliamChief Legal Officer
|
Exercise / conversionCommon stock | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-22-000105 · wf-form4_167226150591374.xml · nonDerivative · entry 1 Burns James William · CIK 0001900772 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 272 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| December 06, 2022 Filed Dec 6, 2022 21:14 UTC |
Gheuens SarahChief Medical Officer
|
Tax withholdingCommon stock | 248 | $28.83 | $7,149.84 |
DisclosureSEC source: 0001439222-22-000101 · wf-form4_167036124284100.xml · nonDerivative · entry 2 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,013 Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 21:14 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionRestricted stock units · Derivative | 833 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-22-000101 · wf-form4_167036124284100.xml · derivative · entry 3 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 833 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on December 2, 2019. Beginning on December 2, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. F3 · derivative.expiration_date: The restricted stock units were granted on December 2, 2019. Beginning on December 2, 2020, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
| December 02, 2022 Filed Dec 6, 2022 21:14 UTC |
Gheuens SarahChief Medical Officer
|
Exercise / conversionCommon stock | 833 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-22-000101 · wf-form4_167036124284100.xml · nonDerivative · entry 1 Gheuens Sarah · CIK 0001881190 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 660 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| October 17, 2022 Filed Oct 18, 2022 20:17 UTC |
Poddar RichaChief Commercial Officer
|
Tax withholdingCommon stock | 1,485 | $27.48 | $40,807.80 |
DisclosureSEC source: 0001439222-22-000091 · wf-form4_166612418262958.xml · nonDerivative · entry 2 Poddar Richa · CIK 0001897274 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,508 Read SEC document |
| October 15, 2022 Filed Oct 18, 2022 20:17 UTC |
Poddar RichaChief Commercial Officer
|
Exercise / conversionRestricted stock units · Derivative | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-22-000091 · wf-form4_166612418262958.xml · derivative · entry 3 Poddar Richa · CIK 0001897274 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022. F3 · derivative.expiration_date: The restricted stock units were granted on October 15, 2020. The shares underlying the restricted stock units will vest in full on October 15, 2022. Read SEC document |
| October 15, 2022 Filed Oct 18, 2022 20:17 UTC |
Poddar RichaChief Commercial Officer
|
Exercise / conversionCommon stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-22-000091 · wf-form4_166612418262958.xml · nonDerivative · entry 1 Poddar Richa · CIK 0001897274 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 312 shares purchased through the Company's employee stock purchase plan. Read SEC document |
| September 26, 2022 Filed Sep 28, 2022 20:10 UTC |
Jones CeciliaChief Financial Officer
|
GrantRestricted stock units · Derivative | 22,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001439222-22-000089 · wf-form4_166439584185254.xml · derivative · entry 2 Jones Cecilia · CIK 0001840056 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,417 Underlying: Common stock · 22,417 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F3 · derivative.exercise_date: The restricted stock units were granted on September 26, 2022. Beginning on September 26, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. F3 · derivative.expiration_date: The restricted stock units were granted on September 26, 2022. Beginning on September 26, 2023, the shares underlying the restricted stock units will vest in three equal annual installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.